| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
Vu Quan Anh is a Chief Financial Officer at Monopar Therapeutics. Recent SEC Form 4 filings include 1 buy and 0 sells.
Estimated insider holdings value: $89K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 26, 2025 | MNPR Monopar Therapeutics | Chief Financial Officer | Buy | 1,500 | $69.95 | $104,925.00 | New | -20.7% | - |